Hitoshi Kurata

422 total citations
21 papers, 343 citations indexed

About

Hitoshi Kurata is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, Hitoshi Kurata has authored 21 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Organic Chemistry. Recurrent topics in Hitoshi Kurata's work include Cholesterol and Lipid Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Chemical Synthesis and Analysis (3 papers). Hitoshi Kurata is often cited by papers focused on Cholesterol and Lipid Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Chemical Synthesis and Analysis (3 papers). Hitoshi Kurata collaborates with scholars based in Japan, Germany and United States. Hitoshi Kurata's co-authors include Takeshi Kitahara, Kenji Mori, Toshiyuki Takagi, Yoshikazu Uto, Yohei Kiyotsuka, Yuko Ueno, Keita Kono, Tsuneo Deguchi, Jun Ohsumi and Tatsuji Matsuoka and has published in prestigious journals such as Tetrahedron, European Journal of Pharmacology and Bone.

In The Last Decade

Hitoshi Kurata

21 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Kurata Japan 13 150 126 65 62 40 21 343
Heinz‐Werner Kleemann Germany 9 164 1.1× 70 0.6× 70 1.1× 36 0.6× 16 0.4× 16 370
Yohei Kiyotsuka Japan 13 159 1.1× 293 2.3× 24 0.4× 35 0.6× 28 0.7× 23 427
Sudershan K. Sanduja United States 11 158 1.1× 83 0.7× 37 0.6× 53 0.9× 218 5.5× 20 496
Hoosang Hwang South Korea 7 182 1.2× 53 0.4× 38 0.6× 43 0.7× 75 1.9× 9 325
Denis Deschênes Canada 9 152 1.0× 226 1.8× 35 0.5× 20 0.3× 89 2.2× 12 374
Tsuneo Yasuma Japan 12 511 3.4× 153 1.2× 72 1.1× 266 4.3× 30 0.8× 18 760
Kern G. Jolibois United States 7 166 1.1× 113 0.9× 44 0.7× 46 0.7× 20 0.5× 7 277
Kebin Wu United States 11 357 2.4× 91 0.7× 39 0.6× 29 0.5× 22 0.6× 19 515
Manorama M. Patel United States 8 193 1.3× 141 1.1× 49 0.8× 20 0.3× 68 1.7× 9 333
Shigeki Sakamaki Japan 6 166 1.1× 213 1.7× 55 0.8× 136 2.2× 51 1.3× 7 452

Countries citing papers authored by Hitoshi Kurata

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Kurata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Kurata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Kurata more than expected).

Fields of papers citing papers by Hitoshi Kurata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Kurata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Kurata. The network helps show where Hitoshi Kurata may publish in the future.

Co-authorship network of co-authors of Hitoshi Kurata

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Kurata. A scholar is included among the top collaborators of Hitoshi Kurata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Kurata. Hitoshi Kurata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uto, Yoshikazu, Yuko Ueno, Yohei Kiyotsuka, et al.. (2011). Discovery of novel SCD1 inhibitors: 5-Alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4′-piperidine] analogs. European Journal of Medicinal Chemistry. 46(5). 1892–1896. 18 indexed citations
2.
Uto, Yoshikazu, Yuko Ueno, Yohei Kiyotsuka, et al.. (2010). Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4′-piperidine] analogs. European Journal of Medicinal Chemistry. 45(11). 4788–4796. 27 indexed citations
3.
Uto, Yoshikazu, Yohei Kiyotsuka, Yuko Ueno, et al.. (2009). Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation. Bioorganic & Medicinal Chemistry Letters. 19(15). 4159–4166. 26 indexed citations
5.
6.
Uto, Yoshikazu, Jun Harada, Yohei Kiyotsuka, et al.. (2009). Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide. Bioorganic & Medicinal Chemistry Letters. 19(15). 4151–4158. 20 indexed citations
7.
Kitayama, Ken, Daisuke Nakai, Keita Kono, et al.. (2006). Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys. European Journal of Pharmacology. 539(1-2). 89–98. 34 indexed citations
8.
Kurata, Hitoshi, Sayaka Suzuki, Takuya Ikeda, et al.. (2004). A Novel Class of Apical Sodium‐Dependent Bile Acid Transporter Inhibitors: The Amphiphilic 4‐Oxo‐1‐phenyl‐1,4‐dihydroquinoline Derivatives.. ChemInform. 35(23). 1 indexed citations
9.
Kurata, Hitoshi, Sayaka Suzuki, Takuya Ikeda, et al.. (2004). A novel class of apical sodium-dependent bile acid transporter inhibitors: the amphiphilic 4-oxo-1-phenyl-1,4-dihydroquinoline derivatives. Bioorganic & Medicinal Chemistry Letters. 14(5). 1183–1186. 14 indexed citations
10.
Nishi, Takahide, Tetsuya Fukazawa, Katsuyoshi Nakajima, et al.. (1999). Combined NK1 and NK2 tachykinin receptor antagonists: Synthesis and structure-activity relationships of novel oxazolidine analogues. Bioorganic & Medicinal Chemistry Letters. 9(6). 875–880. 14 indexed citations
11.
12.
13.
Kurata, Hitoshi, et al.. (1996). Synthesis and testosterone 5α-reductase inhibitory activity of 11-substituted 4-aza-5α-androstane compounds. European Journal of Medicinal Chemistry. 31(9). 675–681. 4 indexed citations
15.
Kojima, Koichi, Katsuyoshi Nakajima, Hitoshi Kurata, Keiichi Tabata, & Yukio Utsui. (1996). Synthesis of a piperidinomethylthiophene derivative as H2-antagonist with inhibitory activity against Helicobacter pylori. Bioorganic & Medicinal Chemistry Letters. 6(15). 1795–1798. 6 indexed citations
16.
Kitahara, Takeshi, et al.. (1994). Facile Preparation of Conjugated Dienes from Allylic Alcohols. Synthesis. 1994(7). 692–694. 10 indexed citations
17.
Kurata, Hitoshi, et al.. (1994). Synthesis of B-NOR-4-AZA-5α-androstane compound as 5α-reductase inhibitor. Bioorganic & Medicinal Chemistry Letters. 4(5). 729–732. 4 indexed citations
18.
Kitahara, Takeshi, Hiromasa Kiyota, Hitoshi Kurata, & Kenji Mori. (1991). Synthesis of oxygenated eremophilanes, gigantenone, phomenone and phaseolinone, phytotoxins from pathogenic fungi. Tetrahedron. 47(9). 1649–1654. 17 indexed citations
19.
Kitahara, Takeshi, Hitoshi Kurata, & Kenji Mori. (1988). Efficient synthesis of the natural enantiomer of sporogen-AO 1 (13-desoxyphomenone) A sporogenic sesquiterpene from aspergillus oryzae. Tetrahedron. 44(14). 4339–4349. 30 indexed citations
20.
Kitahara, Takeshi, Hitoshi Kurata, Tatsuji Matsuoka, & Kenji Mori. (1985). Synthesis of both the enantiomers of sclerosporin and sclerosporal, sporogenic substance of sclerotinia fructicola. Tetrahedron. 41(23). 5475–5485. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026